Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OK Biotech CoTPE:4155 +0.33%60 5-Year Yield-on-Cost % is 0.40 as of Jul. 28, 2026, which is 60% below its 10-year median of 1.01. GuruFocus rates TPE:4155 with a GF Score™ of 60/100 and a GF Value™ of NT$27.22 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 323 Medical Devices & Instruments companies, OK Biotech Co ranks worse than 91.02% on this metric.
OK Biotech Co's yield on cost for the quarter that ended in Dec. 2025 was 0.40.
The historical rank and industry rank for OK Biotech Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TPE:4155'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.25 Med: 1.01 Max: 2.17
Current: 0.4
During the past 13 years, OK Biotech Co's highest Yield on Cost was 2.17. The lowest was 0.25. And the median was 1.01.
TPE:4155's 5-Year Yield-on-Cost % is ranked worse than 91.02% of 323
companies
in the Medical Devices & Instruments industry
Industry Median: 2.51
vs TPE:4155: 0.40
OK Biotech Co (TPE:4155) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
OK Biotech Co 5-Year Yield-on-Cost % Related Terms
TPE:4155 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, OK Biotech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OK Biotech Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OK Biotech Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where OK Biotech Co's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of OK Biotech Co is calculated as
OK Biotech Co (TPE:4155) has a 5-Year Yield-on-Cost % of 0.40 as of Jul. 28, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on OK Biotech Co and its competitors. This is 60% below median its historical median of 1.01. Over the past decade, OK Biotech Co's 5-Year Yield-on-Cost % has ranged from 0.25 to 2.17. According to the industry distribution chart, OK Biotech Co ranks #294 out of 323 companies in the Medical Devices & Instruments industry, placing it in the top 91%.
Is OK Biotech Co's 5-Year Yield-on-Cost % too high?
OK Biotech Co's current 5-Year Yield-on-Cost % of 0.40 is 60% below median its 10-year median of 1.01. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 2.17. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.51. OK Biotech Co's value of 0.40 is 84.1% below this industry median. Based on the distribution chart, OK Biotech Co ranks #294 out of 323 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, OK Biotech Co has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OK Biotech Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, OK Biotech Co ranks #294 out of 323 companies for 5-Year Yield-on-Cost %. This places OK Biotech Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.51. OK Biotech Co's value of 0.40 is 84.1% below this benchmark. Historically, OK Biotech Co's own 5-Year Yield-on-Cost % has ranged from 0.25 to 2.17 over the past decade. While the company's 10-year median is 1.01 vs. the industry median of 2.51, OK Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.51, based on 323 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OK Biotech Co's current 5-Year Yield-on-Cost % of 0.40 is 84.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on OK Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OK Biotech Co's current 5-Year Yield-on-Cost % is 0.40, which is 60% below median its own 10-year median of 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OK Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, OK Biotech Co (TPE:4155) is currently considered Possible Value Trap. The stock's GF Value™ is NT$27.22, compared to a current price of NT$15.40 — trading 43.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.40, which is 60% below median its 10-year median of 1.01 and 84.1% below the Medical Devices & Instruments industry median of 2.51. OK Biotech Co's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For OK Biotech Co (TPE:4155), the current 5-Year Yield-on-Cost % is 0.40 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OK Biotech Co (TPE:4155) Overvalued in 2026?
Based on GuruFocus' analysis, OK Biotech Co stock appears to be undervalued.
The current stock price of NT$15.40 is trading 43.4% below its estimated GF Value™ of NT$27.22.
GuruFocus considers OK Biotech Co to be Possible Value Trap.
Key valuation signals for TPE:4155:
5-Year Yield-on-Cost %: 0.40 (60% below median its 10-year median of 1.01)
GF Value™: NT$27.22 vs. price of NT$15.40 (43.4% below fair value)
Industry Position: 84.1% below the Medical Devices & Instruments median (#294 of 323)
No single metric tells the full story. See the TPE:4155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
60GF Score
Get the complete analysis for TPE:4155
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4155 has been successfully added to your 
